These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38839638)

  • 21. [18F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease.
    Juri C; Kramer V; Riss PJ; Soza-Ried C; Haeger A; Pruzzo R; Rösch F; Amaral H; Chana-Cuevas P
    Clin Nucl Med; 2021 Feb; 46(2):119-124. PubMed ID: 33323728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
    Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
    Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
    J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease.
    Happe S; Baier PC; Helmschmied K; Meller J; Tatsch K; Paulus W
    J Neurol; 2007 Aug; 254(8):1037-43. PubMed ID: 17351722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subregional Pattern of Striatal Dopamine Transporter Loss on 18F FP-CIT Positron Emission Tomography in Patients With Pure Akinesia With Gait Freezing.
    Han S; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Park HK; Kim JS
    JAMA Neurol; 2016 Dec; 73(12):1477-1484. PubMed ID: 27723878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease.
    Lee CS; Kim SJ; Oh SJ; Kim HO; Yun SC; Doudet D; Kim JS
    Ann Nucl Med; 2014 Nov; 28(9):874-9. PubMed ID: 25008292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic properties in functional connectivity changes and striatal dopamine deficiency in Parkinson's disease.
    Asendorf AL; Theis H; Tittgemeyer M; Timmermann L; Fink GR; Drzezga A; Eggers C; Ruppert-Junck MC; Pedrosa DJ; Hoenig MC; van Eimeren T
    Hum Brain Mapp; 2024 Jul; 45(10):e26776. PubMed ID: 38958131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.
    Caminiti SP; Presotto L; Baroncini D; Garibotto V; Moresco RM; Gianolli L; Volonté MA; Antonini A; Perani D
    Neuroimage Clin; 2017; 14():734-740. PubMed ID: 28409113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
    Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P
    Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
    Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
    Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in Parkinson's disease in relation to striatal dopamine transporter binding.
    Mäkinen E; Joutsa J; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2017 Sep; 42():66-72. PubMed ID: 28662820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease.
    Yang R; He C; Zhang P; Li Y; Rong S; Chen X; Qi Q; Gao Z; Chi J; Wang L; Cai M; Zhang Y
    Parkinsonism Relat Disord; 2024 Sep; 126():107071. PubMed ID: 39053098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.
    Hong JY; Oh JS; Lee I; Sunwoo MK; Ham JH; Lee JE; Sohn YH; Kim JS; Lee PH
    Neurology; 2014 May; 82(18):1597-604. PubMed ID: 24719485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. REM sleep behavior disorder in early Parkinson's disease predicts the rapid dopaminergic denervation.
    Kim YE; Kim YJ; Hwang HS; Ma HI
    Parkinsonism Relat Disord; 2020 Nov; 80():120-126. PubMed ID: 32987358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-dependent association of urate on the patterns of striatal dopamine depletion in Parkinson's disease.
    Baik K; Chung SJ; Yoo HS; Lee YH; Jung JH; Sohn YH; Lee PH
    Eur J Neurol; 2020 May; 27(5):773-778. PubMed ID: 31994785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
    Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
    J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
    Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
    Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's disease.
    Happe S; Tings T; Koch W; Welsch J; Helmschmied K; Baier PC; Meller J; Wuttke W; Paulus W; Tatsch K; Trenkwalder C
    J Neural Transm (Vienna); 2007; 114(5):589-94. PubMed ID: 17187291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.